+ Watch ENZ
on My Watchlist
The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.
I was just scavenging around for some green thumbs to take advantage of a market rebound and I found my old friend Enzo, who has recently returned to my fold of score leaders. Enzo is a cyclical, catalyst-deprived biotech currently trading towards the low end of yearly range. Revenues have been essentially static and the pipeline has been quiescent. There's nothing remotely inspiring about Enzo these days except for the low price.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions